Exact Mass: 285.0709

Exact Mass Matches: 285.0709

Found 116 metabolites which its exact mass value is equals to given mass value 285.0709, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

MFCD00049038

5-Deoxy-5-chloroadenosine

C10H12ClN5O3 (285.0629)


   

Cladribine

(2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol

C10H12ClN5O3 (285.0629)


Cladribine is only found in individuals that have used or taken this drug. It is an antineoplastic agent used in the treatment of lymphoproliferative diseases including hairy-cell leukemia. [PubChem]Cladribine is structurally related to fludarabine and pentostatin but has a different mechanism of action. Although the exact mechanism of action has not been fully determined, evidence shows that cladribine is phosphorylated by deoxycytidine kinase to the nucleotidecladribine triphosphate (CdATP; 2-chloro-2′-deoxyadenosine 5′-triphosphate), which accumulates and is incorporated into DNA in cells such as lymphocytes that contain high levels of deoxycytidine kinase and low levels of deoxynucleotidase, resulting in DNA strand breakage and inhibition of DNA synthesis and repair. High levels of CdATP also appear to inhibit ribonucleotide reductase, which leads to an imbalance in triphosphorylated deoxynucleotide (dNTP) pools and subsequent DNA strand breaks, inhibition of DNA synthesis and repair, nicotinamide adenine dinucleotide (NAD) and ATP depletion, and cell death. Unlike other antimetabolite drugs, cladribine has cytotoxic effects on resting as well as proliferating lymphocytes. However, it does cause cells to accumulate at the G1/S phase junction, suggesting that cytotoxicity is associated with events critical to cell entry into S phase. It also binds purine nucleoside phosphorylase (PNP), however no relationship between this binding and a mechanism of action has been established. L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BB - Purine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents C471 - Enzyme Inhibitor > C2157 - Adenosine Deaminase Inhibitor C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D000970 - Antineoplastic Agents Cladribine (2-Chloro-2′-deoxyadenosine), a purine nucleoside analog, is an orally active adenosine deaminase inhibitor. Cladribine functions as an inhibitor of DNA synthesis to block the repair of the damaged DNA. Cladribine can inhibit DNA methylation. Cladribine has anti-lymphoma activity. Cladribine can be used for the research of several hematologic malignancies and multiple sclerosis[1][2].

   

7-Aminoclonazepam

7-amino-5-(2-chlorophenyl)-3H-1,4-benzodiazepin-2-ol

C15H12ClN3O (285.0669)


7-aminoclonazepam belongs to the family of Benzodiazepines. These are organic compounds containing a benzene ring fused to either isomers of diazepine(unsaturated seven-member heterocycle with two nitrogen atoms replacing two carbon atoms).

   

Faropenem

(+)-(5R,6S)-6-((1R)-1-Hydroxyethyl)-7-oxo-3-((2R)-tetrahydro-2-furyl)-4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid

C12H15NO5S (285.0671)


Faropenem is an orally active beta-lactam antibiotic belonging to the penem group. It is resistant to some forms of extended-spectrum beta-lactamase. It is available for oral use. Faropenem was developed by Daiichi Asubio Pharma, which markets it in two forms. The sodium salt faropenem sodium, available under the trade name Farom, has been marketed in Japan since 1997. (CID 636379 from PubChem) The prodrug form faropenem medoxomil (also known as faropenem daloxate) has been licensed from Daiichi Asubio Pharma by Replidyne, which plans to market it in conjunction with Forest Pharmaceuticals. The trade name proposed for the product was Orapem, but company officials recently announced this name was rejected by the FDA.

   

2,5-Dioxopyrrolidin-1-yl quinolin-6-ylcarbamate

2,5-dioxopyrrolidin-1-yl N-(quinolin-6-yl)carbamate

C14H11N3O4 (285.075)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents

   

2-Chloro-3'-deoxyadenosine

2-(6-amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)oxolan-3-ol

C10H12ClN5O3 (285.0629)


   

Flunoxaprofen

2-[2-(4-fluorophenyl)-1,3-benzoxazol-5-yl]propanoic acid

C16H12FNO3 (285.0801)


   

2-Chloro-9-(2-deoxy-beta-D-arabinofuranosyl)adenine

5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol

C10H12ClN5O3 (285.0629)


   

2-Amino-9-(6-oxo-1H-purin-9-yl)-1H-purin-6-one

2-Amino-9-(6-oxo-1H-purin-9-yl)-1H-purin-6-one

C10H7N9O2 (285.0723)


   

3H-1,4-Benzodiazepin-2-amine, 7-chloro-5-phenyl-, 4-oxide

7-chloro-2-imino-5-phenyl-3,4-dihydro-2H-1,4-benzodiazepin-4-ol

C15H12ClN3O (285.0669)


   

Theasaponin E3

(2S)-3-hydroxy-2-(2-nitrophenyl)-1,2,3,4-tetrahydroquinazolin-4-one

C14H11N3O4 (285.075)


Theasaponin e3 is a member of the class of compounds known as quinazolines. Quinazolines are compounds containing a quinazoline moiety, which is made up of two fused six-member aromatic rings, a benzene ring and a pyrimidine ring. Theasaponin e3 is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Theasaponin e3 can be found in tea, which makes theasaponin e3 a potential biomarker for the consumption of this food product.

   
   
   
   

Bezerramycin A

Bezerramycin A

C14H11N3O4 (285.075)


   

Actinomycinol

Actinomycinol

C15H11NO5 (285.0637)


   
   

Cladribine

Cladribine

C10H12ClN5O3 (285.0629)


L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BB - Purine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents C471 - Enzyme Inhibitor > C2157 - Adenosine Deaminase Inhibitor C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D000970 - Antineoplastic Agents CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2617; ORIGINAL_PRECURSOR_SCAN_NO 2616 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2634; ORIGINAL_PRECURSOR_SCAN_NO 2632 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2626; ORIGINAL_PRECURSOR_SCAN_NO 2625 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2623; ORIGINAL_PRECURSOR_SCAN_NO 2621 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2643; ORIGINAL_PRECURSOR_SCAN_NO 2642 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2641; ORIGINAL_PRECURSOR_SCAN_NO 2639 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5653; ORIGINAL_PRECURSOR_SCAN_NO 5650 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5671; ORIGINAL_PRECURSOR_SCAN_NO 5668 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5700; ORIGINAL_PRECURSOR_SCAN_NO 5699 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5680; ORIGINAL_PRECURSOR_SCAN_NO 5677 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5706; ORIGINAL_PRECURSOR_SCAN_NO 5702 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5693; ORIGINAL_PRECURSOR_SCAN_NO 5691 Cladribine (2-Chloro-2′-deoxyadenosine), a purine nucleoside analog, is an orally active adenosine deaminase inhibitor. Cladribine functions as an inhibitor of DNA synthesis to block the repair of the damaged DNA. Cladribine can inhibit DNA methylation. Cladribine has anti-lymphoma activity. Cladribine can be used for the research of several hematologic malignancies and multiple sclerosis[1][2].

   

7-Aminoclonazepam

7-Aminoclonazepam

C15H12ClN3O (285.0669)


   

8-Chloro-deoxyadenosine

8-Chloro-deoxyadenosine

C10H12Cl1N5O3 (285.0629)


   

2-Chloro-deoxyadenosine

2-Chloro-deoxyadenosine

C10H12Cl1N5O3 (285.0629)


   

2-(BENZOYLAMINO)-4-(METHYLSULFONYL)BUTANOIC ACID

2-(BENZOYLAMINO)-4-(METHYLSULFONYL)BUTANOIC ACID

C12H15NO5S (285.0671)


   

4-HYDROXY-1-[(4-METHYLPHENYL)SULFONYL]-2-PYRROLIDINECARBOXYLIC ACID

4-HYDROXY-1-[(4-METHYLPHENYL)SULFONYL]-2-PYRROLIDINECARBOXYLIC ACID

C12H15NO5S (285.0671)


   

3-AMINO-7-CHLORO-5-PHENYL-1,3-DIHYDRO-BENZO[E][1,4]DIAZEPIN-2-ONE

3-AMINO-7-CHLORO-5-PHENYL-1,3-DIHYDRO-BENZO[E][1,4]DIAZEPIN-2-ONE

C15H12ClN3O (285.0669)


   

flunoxaprofen

flunoxaprofen

C16H12FNO3 (285.0801)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CC - Antiinflammatory products for vaginal administration C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

1-(4-methoxyphenyl)sulfonylpyrrolidine-2-carboxylic acid

1-(4-methoxyphenyl)sulfonylpyrrolidine-2-carboxylic acid

C12H15NO5S (285.0671)


   

Piperazine, 1-[4-(methylsulfonyl)-2-nitrophenyl]- (9CI)

Piperazine, 1-[4-(methylsulfonyl)-2-nitrophenyl]- (9CI)

C11H15N3O4S (285.0783)


   

9-(trifluoromethyl)-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazoline-2-carboxylic acid

9-(trifluoromethyl)-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazoline-2-carboxylic acid

C12H10F3N3O2 (285.0725)


   

(2R,4S)-4-hydroxy-1-(4-methylphenyl)sulfonyl-pyrrolidine-2-carboxylate

(2R,4S)-4-hydroxy-1-(4-methylphenyl)sulfonyl-pyrrolidine-2-carboxylate

C12H15NO5S (285.0671)


   

N-(3-Methylsulphonyl-4-nitrophenyl)piperazine

N-(3-Methylsulphonyl-4-nitrophenyl)piperazine

C11H15N3O4S (285.0783)


   

4-(Methylsulfonyl)-3-morpholinobenzoic Acid

4-(Methylsulfonyl)-3-morpholinobenzoic Acid

C12H15NO5S (285.0671)


   

N-BOC-N-METHYL-5-CHLOROANTHRANILICACID

N-BOC-N-METHYL-5-CHLOROANTHRANILICACID

C13H16ClNO4 (285.0768)


   

ANTHRANILICACID,N-BOC-N-METHYL-4-CHLORO

ANTHRANILICACID,N-BOC-N-METHYL-4-CHLORO

C13H16ClNO4 (285.0768)


   

7-nitro-4-(pyridin-2-ylmethyl)-2H-benzo[b][1,4]oxazin-3(4H)-one

7-nitro-4-(pyridin-2-ylmethyl)-2H-benzo[b][1,4]oxazin-3(4H)-one

C14H11N3O4 (285.075)


   

2-AMINO-6-CHLORO-9-(BETA-D-2-DEOXYRIBOFURANOSYL)PURINE

2-AMINO-6-CHLORO-9-(BETA-D-2-DEOXYRIBOFURANOSYL)PURINE

C10H12ClN5O3 (285.0629)


   

Ethyl 4-oxo-7-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxylate

Ethyl 4-oxo-7-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxylate

C13H10F3NO3 (285.0613)


   

Methyl 8-methyl-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-2-carboxylate

Methyl 8-methyl-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-2-carboxylate

C13H10F3NO3 (285.0613)


   

6-NITRO-4-(PYRIDINE-2-YLMETHYL)-1,4-BENZOXAZIN-3(4H)-ONE

6-NITRO-4-(PYRIDINE-2-YLMETHYL)-1,4-BENZOXAZIN-3(4H)-ONE

C14H11N3O4 (285.075)


   

Benzeneacetic acid,2-chloro-a-[[(1,1-dimethylethoxy)carbonyl]amino]-

Benzeneacetic acid,2-chloro-a-[[(1,1-dimethylethoxy)carbonyl]amino]-

C13H16ClNO4 (285.0768)


   

(S)-6-(PROPYLAMINO)-5,6,7,8-TETRAHYDRONAPHTHALEN-1-OL HYDROBROMIDE

(S)-6-(PROPYLAMINO)-5,6,7,8-TETRAHYDRONAPHTHALEN-1-OL HYDROBROMIDE

C13H20BrNO (285.0728)


   

(s)-n-boc-(2-chlorophenyl)glycine

(s)-n-boc-(2-chlorophenyl)glycine

C13H16ClNO4 (285.0768)


   

3-(4-Bromophenoxy)-N,N-diethyl-1-propanamine

3-(4-Bromophenoxy)-N,N-diethyl-1-propanamine

C13H20BrNO (285.0728)


   

Ethyl 4-hydroxy-8-(trifluoromethyl)quinoline-3-carboxylate

Ethyl 4-hydroxy-8-(trifluoromethyl)quinoline-3-carboxylate

C13H10F3NO3 (285.0613)


   

N-Benzanilide-4,4-dicarboxylic acid

N-Benzanilide-4,4-dicarboxylic acid

C15H11NO5 (285.0637)


   

1-Butylpyridinium trifluoromethanesulfonate

1-Butylpyridinium trifluoromethanesulfonate

C10H14F3NO3S (285.0646)


   

3-Quinolinecarboxylicacid, 4-hydroxy-7-(trifluoromethyl)-, ethyl ester

3-Quinolinecarboxylicacid, 4-hydroxy-7-(trifluoromethyl)-, ethyl ester

C13H10F3NO3 (285.0613)


   

2-(1-PIPERAZINYL)-QUINOLINEHYDROCHLORIDE

2-(1-PIPERAZINYL)-QUINOLINEHYDROCHLORIDE

C13H17Cl2N3 (285.0799)


   

(S)-2-((TERT-BUTOXYCARBONYL)AMINO)-2-(4-CHLOROPHENYL)ACETIC ACID

(S)-2-((TERT-BUTOXYCARBONYL)AMINO)-2-(4-CHLOROPHENYL)ACETIC ACID

C13H16ClNO4 (285.0768)


   

(2R)-2-(3-chlorophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid

(2R)-2-(3-chlorophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid

C13H16ClNO4 (285.0768)


   

7,8-dimethyl-4,5-dioxo-6H-pyrano[3,2-c]quinoline-2-carboxylic acid

7,8-dimethyl-4,5-dioxo-6H-pyrano[3,2-c]quinoline-2-carboxylic acid

C15H11NO5 (285.0637)


   

2-CARBOXY-PHTHALANIC ACID

2-CARBOXY-PHTHALANIC ACID

C15H11NO5 (285.0637)


   

Ethyl 4-hydroxy-2-(trifluoromethyl)quinoline-3-carboxylate

Ethyl 4-hydroxy-2-(trifluoromethyl)quinoline-3-carboxylate

C13H10F3NO3 (285.0613)


   

ethyl 2-(4-acetamidophenyl)sulfonylacetate

ethyl 2-(4-acetamidophenyl)sulfonylacetate

C12H15NO5S (285.0671)


   

3-{[(tert-Butoxycarbonyl)amino]methyl}-4-chlorobenzoic acid

3-{[(tert-Butoxycarbonyl)amino]methyl}-4-chlorobenzoic acid

C13H16ClNO4 (285.0768)


   

N-(4-Methylsulphonyl-3-nitrophenyl)piperazine

N-(4-Methylsulphonyl-3-nitrophenyl)piperazine

C11H15N3O4S (285.0783)


   

4-(Methylsulfonyl)-2-morpholinobenzoic Acid

4-(Methylsulfonyl)-2-morpholinobenzoic Acid

C12H15NO5S (285.0671)


   

2-[2-chloro-3-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]acetic acid

2-[2-chloro-3-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]acetic acid

C13H16ClNO4 (285.0768)


   

N-Boc-(4-Chlorophenyl)glycine

N-Boc-(4-Chlorophenyl)glycine

C13H16ClNO4 (285.0768)


   

N-Boc-(3-chlorophenyl)glycine

N-Boc-(3-chlorophenyl)glycine

C13H16ClNO4 (285.0768)


   

4-METHYL-3-(MORPHOLINE-4-SULFONYL)BENZOICACID

4-METHYL-3-(MORPHOLINE-4-SULFONYL)BENZOICACID

C12H15NO5S (285.0671)


   

1-METHYL-4-(4-NITRO-BENZENESULFONYL)-PIPERAZINE

1-METHYL-4-(4-NITRO-BENZENESULFONYL)-PIPERAZINE

C11H15N3O4S (285.0783)


   

5-(1-methylcyclopropyl)-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxylic acid

5-(1-methylcyclopropyl)-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxylic acid

C12H10F3N3O2 (285.0725)


   

METHYL 2-(MORPHOLINOSULFONYL)BENZOATE

METHYL 2-(MORPHOLINOSULFONYL)BENZOATE

C12H15NO5S (285.0671)


   

METHYL 3-METHYL-5-[4-(TRIFLUOROMETHYL)PHENYL]ISOXAZOLE-4-CARBOXYLATE

METHYL 3-METHYL-5-[4-(TRIFLUOROMETHYL)PHENYL]ISOXAZOLE-4-CARBOXYLATE

C13H10F3NO3 (285.0613)


   

1-methylsulfonyl-4-(4-nitrophenyl)piperazine

1-methylsulfonyl-4-(4-nitrophenyl)piperazine

C11H15N3O4S (285.0783)


   

ETHYL 5-(4-(TRIFLUOROMETHYL)PHENYL)ISOXAZOLE-3-CARBOXYLATE

ETHYL 5-(4-(TRIFLUOROMETHYL)PHENYL)ISOXAZOLE-3-CARBOXYLATE

C13H10F3NO3 (285.0613)


   

Ethyl 4-hydroxy-6-(trifluoromethyl)quinoline-3-carboxylate

Ethyl 4-hydroxy-6-(trifluoromethyl)quinoline-3-carboxylate

C13H10F3NO3 (285.0613)


   

4-[(TETRAHYDRO-FURAN-2-YLMETHYL)-SULFAMOYL]-BENZOIC ACID

4-[(TETRAHYDRO-FURAN-2-YLMETHYL)-SULFAMOYL]-BENZOIC ACID

C12H15NO5S (285.0671)


   

[3-(methylthio)-1-(3-phenyl-1,2,4-oxadiazol-5-yl)propyl]amine hydrochloride

[3-(methylthio)-1-(3-phenyl-1,2,4-oxadiazol-5-yl)propyl]amine hydrochloride

C12H16ClN3OS (285.0703)


   

5-(3-TRIFLUOROMETHYLPHENYL)-ISOXAZOLE-3-CARBOXYLIC ACID ETHYL ESTER

5-(3-TRIFLUOROMETHYLPHENYL)-ISOXAZOLE-3-CARBOXYLIC ACID ETHYL ESTER

C13H10F3NO3 (285.0613)


   

N-Boc-2-(4-chlorophenyl)-DL-glycine

N-Boc-2-(4-chlorophenyl)-DL-glycine

C13H16ClNO4 (285.0768)


   

2,5-Pyrrolidinedicarboxylic acid, 1-(phenylmethyl)-, hydrochloride (9CI)

2,5-Pyrrolidinedicarboxylic acid, 1-(phenylmethyl)-, hydrochloride (9CI)

C13H16ClNO4 (285.0768)


   

1-(2-nitrophenyl)sulfonylpiperidin-4-amine

1-(2-nitrophenyl)sulfonylpiperidin-4-amine

C11H15N3O4S (285.0783)


   

1-[2-(4-CHLOROPHENYL)-7-METHYLPYRAZOLO[1,5-A]PYRIMIDIN-6-YL]ETHAN-1-ONE

1-[2-(4-CHLOROPHENYL)-7-METHYLPYRAZOLO[1,5-A]PYRIMIDIN-6-YL]ETHAN-1-ONE

C15H12ClN3O (285.0669)


   

Adenosine,8-chloro-2-deoxy- (9CI)

Adenosine,8-chloro-2-deoxy- (9CI)

C10H12ClN5O3 (285.0629)


   

N-(5-METHYLSULPHONYL-2-NITROPHENYL)PIPERAZINE

N-(5-METHYLSULPHONYL-2-NITROPHENYL)PIPERAZINE

C11H15N3O4S (285.0783)


   

5-BENZOXAZOLEACETIC ACID, 2-(4-FLUOROPHENYL)-alpha-METHYL-

5-BENZOXAZOLEACETIC ACID, 2-(4-FLUOROPHENYL)-alpha-METHYL-

C16H12FNO3 (285.0801)


   

5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol

5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol

C10H12ClN5O3 (285.0629)


   
   

gentisate 5-O-beta-D-xylopyranoside

gentisate 5-O-beta-D-xylopyranoside

C12H13O8- (285.061)


D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates

   

(Z)-3-(4-hydroxy-2-methoxyphenyl)-1-(4-hydroxyphenyl)-3-oxoprop-1-en-1-olate

(Z)-3-(4-hydroxy-2-methoxyphenyl)-1-(4-hydroxyphenyl)-3-oxoprop-1-en-1-olate

C16H13O5- (285.0763)


   

4-dihydro-9-hydroxy-1-methyl-10-oxo-3-H-naptho-[2,3-c]-pyran-3-(S)-acetic acid

4-dihydro-9-hydroxy-1-methyl-10-oxo-3-H-naptho-[2,3-c]-pyran-3-(S)-acetic acid

C16H13O5- (285.0763)


   

3-[4-(2-methylphenyl)-5-sulfanylidene-1H-1,2,4-triazol-3-yl]-1H-pyridazin-6-one

3-[4-(2-methylphenyl)-5-sulfanylidene-1H-1,2,4-triazol-3-yl]-1H-pyridazin-6-one

C13H11N5OS (285.0684)


   

7-Chloro-2-methyl-3-(pyridin-4-ylmethyl)quinazolin-4-one

7-Chloro-2-methyl-3-(pyridin-4-ylmethyl)quinazolin-4-one

C15H12ClN3O (285.0669)


   

2-O-methyllicodione(1-)

2-O-methyllicodione(1-)

C16H13O5- (285.0763)


   

N-(5-amino-1-phenyl-1,2,4-triazol-3-yl)-2-thiophenecarboxamide

N-(5-amino-1-phenyl-1,2,4-triazol-3-yl)-2-thiophenecarboxamide

C13H11N5OS (285.0684)


   

1-Tert-butyl-3-[[(2-chlorophenyl)-oxomethyl]amino]thiourea

1-Tert-butyl-3-[[(2-chlorophenyl)-oxomethyl]amino]thiourea

C12H16ClN3OS (285.0703)


   

2-(4-Chloro-2-methylphenoxy)acetic acid [2-(ethylamino)-2-oxoethyl] ester

2-(4-Chloro-2-methylphenoxy)acetic acid [2-(ethylamino)-2-oxoethyl] ester

C13H16ClNO4 (285.0768)


   

(3-Chloro-phenyl)-(6,7-dihydro-5H-cyclopenta[d][1,2,4]triazolo[1,5-a]pyrimidin-8-yl)-amine

(3-Chloro-phenyl)-(6,7-dihydro-5H-cyclopenta[d][1,2,4]triazolo[1,5-a]pyrimidin-8-yl)-amine

C14H12ClN5 (285.0781)


   

rubrofusarin B(1-)

rubrofusarin B(1-)

C16H13O5- (285.0763)


A phenolate anion obtained by deprotonation of the 5-hydroxy group of rubrofusarin B. It is the major microspecies at pH 7.3.

   

(3R)-5-(6-amino-2-chloro-9-purinyl)-2-(hydroxymethyl)-3-oxolanol

(3R)-5-(6-amino-2-chloro-9-purinyl)-2-(hydroxymethyl)-3-oxolanol

C10H12ClN5O3 (285.0629)


   

6beta-[(S)-1-hydroxyethyl]-2-[(R)-tetrahydrofuran-2-yl]pen-2-em-3-carboxylic acid

6beta-[(S)-1-hydroxyethyl]-2-[(R)-tetrahydrofuran-2-yl]pen-2-em-3-carboxylic acid

C12H15NO5S (285.0671)


   

4-[[4-[Nitroso(oxo)methyl]phenyl]hydrazo]benzoic acid

4-[[4-[Nitroso(oxo)methyl]phenyl]hydrazo]benzoic acid

C14H11N3O4 (285.075)


   

2,3-dihydrobiochanin A(1-)

2,3-dihydrobiochanin A(1-)

C16H13O5- (285.0763)


Conjugate base of 2,3-dihydrobiochanin A arising from selective deprotonation of the 7-hydroxy group.

   

(5R)-6-(1-hydroxyethyl)-7-oxo-3-[(2R)-tetrahydrofuran-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

(5R)-6-(1-hydroxyethyl)-7-oxo-3-[(2R)-tetrahydrofuran-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C12H15NO5S (285.0671)


   

2-hydroxyphenyl beta-D-glucopyranosiduronate

2-hydroxyphenyl beta-D-glucopyranosiduronate

C12H13O8- (285.061)


   

(5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-(oxolan-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

(5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-(oxolan-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C12H15NO5S (285.0671)


   

(5R,6S)-6-[(1S)-1-hydroxyethyl]-7-oxo-3-[(2R)-oxolan-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

(5R,6S)-6-[(1S)-1-hydroxyethyl]-7-oxo-3-[(2R)-oxolan-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C12H15NO5S (285.0671)


   

5-Chloro-5-deoxyadenosine

5-Chloro-5-deoxyadenosine

C10H12ClN5O3 (285.0629)


   

6alpha-[(R)-1-hydroxyethyl]-2-[(R)-tetrahydrofuran-2-yl]pen-2-em-3-carboxylic acid

6alpha-[(R)-1-hydroxyethyl]-2-[(R)-tetrahydrofuran-2-yl]pen-2-em-3-carboxylic acid

C12H15NO5S (285.0671)


   
   

catechol beta-D-glucuronide(1-)

catechol beta-D-glucuronide(1-)

C12H13O8 (285.061)


A carbohydrate acid derivative anion resulting from the removal of a proton from the carboxy group of catechol beta-D-glucuronide.

   

4'-C-Azidouridine

4'-C-Azidouridine

C9H11N5O6 (285.0709)


4'-C-azidouridine (4'-Azidouridine) is a uridine analogue. Uridine has potential antiepileptic effects, and its analogs can be used to study anticonvulsant and anxiolytic activities, as well as to develop new antihypertensive agents[1]. 4'-C-Azidouridine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.

   

Nucleoside-Analog-2

Nucleoside-Analog-2

C9H11N5O6 (285.0709)


Nucleoside-Analog-2 is a 4'-Azidocytidine analogue against Hepatitis C virus (HCV) replication. Nucleoside-Analog-2 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.

   

SIRT7 inhibitor 97491

SIRT7 inhibitor 97491

C15H12ClN3O (285.0669)


SIRT7 inhibitor 97491, a potent SIRT7 inhibitor with an IC50 of 325 nM, reduces deacetylase activity of SIRT7 in a dose-dependent manner. SIRT7 inhibitor 97491 prevents tumor progression by increasing p53 stability through acetylation at K373/382. SIRT7 inhibitor 97491 promotes apoptosis through caspase pathway.[1].

   

(2r)-2,3-bis(formyloxy)propoxy(2-(methylamino)ethoxy)phosphinic acid

(2r)-2,3-bis(formyloxy)propoxy(2-(methylamino)ethoxy)phosphinic acid

C8H16NO8P (285.0614)


   

5-hydroxy-7-methoxy-3-methyl-2h-cyclohexa[g]isoquinoline-6,9,10-trione

5-hydroxy-7-methoxy-3-methyl-2h-cyclohexa[g]isoquinoline-6,9,10-trione

C15H11NO5 (285.0637)


   

4-hydroxy-2,3-dimethoxybenzo[g]quinoline-5,10-dione

4-hydroxy-2,3-dimethoxybenzo[g]quinoline-5,10-dione

C15H11NO5 (285.0637)


   

2,6-dihydroxy-3-methoxy-4-methylbenzo[g]quinoline-5,10-dione

2,6-dihydroxy-3-methoxy-4-methylbenzo[g]quinoline-5,10-dione

C15H11NO5 (285.0637)


   

methyl 2-methoxy-1,5-dioxopyrrolo[1,2-a]quinoline-4-carboxylate

methyl 2-methoxy-1,5-dioxopyrrolo[1,2-a]quinoline-4-carboxylate

C15H11NO5 (285.0637)


   

7,9-dihydroxy-6-methoxy-3-methylbenzo[g]isoquinoline-5,10-dione

7,9-dihydroxy-6-methoxy-3-methylbenzo[g]isoquinoline-5,10-dione

C15H11NO5 (285.0637)


   

2-amino-8-(hydroxymethyl)-3-oxophenoxazine-1-carboximidic acid

2-amino-8-(hydroxymethyl)-3-oxophenoxazine-1-carboximidic acid

C14H11N3O4 (285.075)


   

5,10-dihydroxy-7-methoxy-3-methylcyclohexa[g]isoquinoline-6,9-dione

5,10-dihydroxy-7-methoxy-3-methylcyclohexa[g]isoquinoline-6,9-dione

C15H11NO5 (285.0637)


   

4-[(1z)-2-hydroxyethenyl]phenyl (3z)-3-(hydroxyimino)-4-oxocyclohexa-1,5-diene-1-carboxylate

4-[(1z)-2-hydroxyethenyl]phenyl (3z)-3-(hydroxyimino)-4-oxocyclohexa-1,5-diene-1-carboxylate

C15H11NO5 (285.0637)


   

4-(2-hydroxyethenyl)phenyl 4-hydroxy-3-nitrosobenzoate

4-(2-hydroxyethenyl)phenyl 4-hydroxy-3-nitrosobenzoate

C15H11NO5 (285.0637)